Pramod Prabhakar Wangikar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pramod Prabhakar Wangikar has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
- Damini Jaiswal
Department of Chemical Engineering Indian Institute of Technology Bombay Powai Mumbai 400076 India
12 shared publications Avinash Vellore Sunder
Indian Institute of Technology Bombay
11 shared publicationsDeepti Sahasrabuddhe
Indian Institute of Technology Bombay
11 shared publicationsVivek Mishra
Clarity Bio Systems India Pvt. Ltd., Pune, India
11 shared publicationsAnnesha Sengupta
Indian Institute of Technology Bombay Department of Chemical Engineering
9 shared publicationsHardik Dodia
Department of Chemical Engineering Indian Institute of Technology Bombay Powai Mumbai India
7 shared publications
Latest Publications
- 12 October 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (43) , 29937-29946
Emzing: A Deep Learning-Enabled Software Suite for End-to-End Analysis of High-Resolution LC-MS Metabolomics Data
High-resolution LC-MS-based metabolomics requires transforming noise-dominated raw data into quantitative feature tables and, ultimately, biologically meaningful insights. In practice, this process is fragmented across multiple tools and involves extensive parameter tuning and manual curation. Emzing is a web-based, vendor-agnostic platform that integrates end-to-end analysis, from raw data interrogation to statistical interpretation, within a unified environment. Emzing introduces data-driven, deep learning-based methods for signal extraction and feature quantification, formulating peak detection as a supervised learning problem in both spectral and chromatographic domains. A data-driven noise estimation strategy replaces fixed intensity thresholds, improving sensitivity to low-intensity signals. Feature correspondence across samples is established using robust retention-time alignment and graph-based grouping, while correlation-driven feature tagging assigns isotopes, adducts, and in-source fragments. Metabolite annotation (MSI level 2) combines spectral denoising with composite scoring of MS/MS spectra against reference libraries. Emzing further integrates processing with downstream statistical and machine learning-based analyses to facilitate reliable biological interpretation. Interactive visualization across all stages enables transparent curation and rapid iteration from initial results to publication-quality outputs. The use of pretrained models in inference mode, together with a reduced parameter space, supports reproducible analysis. Emzing improves true-feature recovery, quantitation accuracy, and reproducibility on benchmark data sets while reducing reliance on manual intervention. Scalability is demonstrated through Emzing Vault, a repository containing over 110 reprocessed public domain data sets.
- 12 October 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (43) , 29937-29946
Emzing: A Deep Learning-Enabled Software Suite for End-to-End Analysis of High-Resolution LC-MS Metabolomics Data
High-resolution LC-MS-based metabolomics requires transforming noise-dominated raw data into quantitative feature tables and, ultimately, biologically meaningful insights. In practice, this process is fragmented across multiple tools and involves extensive parameter tuning and manual curation. Emzing is a web-based, vendor-agnostic platform that integrates end-to-end analysis, from raw data interrogation to statistical interpretation, within a unified environment. Emzing introduces data-driven, deep learning-based methods for signal extraction and feature quantification, formulating peak detection as a supervised learning problem in both spectral and chromatographic domains. A data-driven noise estimation strategy replaces fixed intensity thresholds, improving sensitivity to low-intensity signals. Feature correspondence across samples is established using robust retention-time alignment and graph-based grouping, while correlation-driven feature tagging assigns isotopes, adducts, and in-source fragments. Metabolite annotation (MSI level 2) combines spectral denoising with composite scoring of MS/MS spectra against reference libraries. Emzing further integrates processing with downstream statistical and machine learning-based analyses to facilitate reliable biological interpretation. Interactive visualization across all stages enables transparent curation and rapid iteration from initial results to publication-quality outputs. The use of pretrained models in inference mode, together with a reduced parameter space, supports reproducible analysis. Emzing improves true-feature recovery, quantitation accuracy, and reproducibility on benchmark data sets while reducing reliance on manual intervention. Scalability is demonstrated through Emzing Vault, a repository containing over 110 reprocessed public domain data sets.
- Open Access
- 3 September 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Emzing: A deep learning-enabled software suite for end-to-end analysis of high-resolution LC-MS metabolomics data
High-resolution LC–MS metabolomics requires transforming noise-dominated raw data into quantitative feature tables and, ultimately, biologically meaningful insights. In practice, this process is fragmented across multiple tools and involves extensive parameter tuning and manual curation. Emzing is a web-based, vendor-agnostic platform that integrates end-to-end analysis, from raw data interrogation to statistical interpretation, within a unified environment. Emzing introduces data-driven, deep learning–based methods for signal extraction and feature quantification, formulating peak detection as a supervised learning problem in both spectral and chromatographic domains. A data-driven noise estimation strategy replaces fixed intensity thresholds, improving sensitivity to low-intensity signals. Feature correspondence across samples is established using robust retention-time alignment and graph-based grouping, while correlation-driven feature tagging assigns isotopes, adducts, and in-source fragments. Metabolite annotation (MSI level 2) combines spectral denoising with composite scoring of MS/MS spectra against reference libraries. Emzing further integrates processing with downstream statistical and machine learning–based analyses to facilitate reliable biological interpretation. Interactive visualization across all stages enables transparent curation and rapid iteration from initial results to publication-quality outputs. The use of pre-trained models in inference mode, together with a reduced parameter space, supports reproducible analysis. Emzing improves true-feature recovery, quantitative accuracy, and reproducibility on benchmark datasets while reducing reliance on manual intervention. Scalability is demonstrated through Emzing Vault, a repository containing over 110 reprocessed public domain datasets.
- 3 September 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessEmzing: A deep learning-enabled software suite for end-to-end analysis of high-resolution LC-MS metabolomics data
High-resolution LC–MS metabolomics requires transforming noise-dominated raw data into quantitative feature tables and, ultimately, biologically meaningful insights. In practice, this process is fragmented across multiple tools and involves extensive parameter tuning and manual curation. Emzing is a web-based, vendor-agnostic platform that integrates end-to-end analysis, from raw data interrogation to statistical interpretation, within a unified environment. Emzing introduces data-driven, deep learning–based methods for signal extraction and feature quantification, formulating peak detection as a supervised learning problem in both spectral and chromatographic domains. A data-driven noise estimation strategy replaces fixed intensity thresholds, improving sensitivity to low-intensity signals. Feature correspondence across samples is established using robust retention-time alignment and graph-based grouping, while correlation-driven feature tagging assigns isotopes, adducts, and in-source fragments. Metabolite annotation (MSI level 2) combines spectral denoising with composite scoring of MS/MS spectra against reference libraries. Emzing further integrates processing with downstream statistical and machine learning–based analyses to facilitate reliable biological interpretation. Interactive visualization across all stages enables transparent curation and rapid iteration from initial results to publication-quality outputs. The use of pre-trained models in inference mode, together with a reduced parameter space, supports reproducible analysis. Emzing improves true-feature recovery, quantitative accuracy, and reproducibility on benchmark datasets while reducing reliance on manual intervention. Scalability is demonstrated through Emzing Vault, a repository containing over 110 reprocessed public domain datasets.
- Open Access
Ontology-guided harmonization enables unified discovery of public metabolomics studies within and across repositories
Public metabolomics repositories contain thousands of studies, but differences in metadata structure, vocabulary, and repository-specific terms still limit reliable search, comparison, and reuse within and across databases. Here we present HARMONY, an ontology-based framework and web platform that harmonizes study-level metadata and metabolite information across Metabolomics Workbench and MetaboLights studies. HARMONY resolves eight biological and analytical metadata nodes, including species, sample source, disease, analytical technique, separation method, ion polarity, ionization source, and mass analyzer type, while preserving the original deposited terms as evidence. A ninth node, metabolite identity, maps metabolite entities to RefMet across both repositories. HARMONY uses a two-step workflow: Multi-source extraction retrieves records missed by single-field lookups, and ontology mapping then converts repository-specific labels into shared query terms, substantially closing the cross-repository retrieval gap relative to raw matching. Across the full corpus, HARMONY increased cross-repository retrievability from 75.5% to 89.6%, yielding thousands of study-node retrievals and reconnecting studies that raw-text search would have left unreachable within their own repositories. Approximately 91% of Metabolomics Workbench and 85% of MetaboLights studies had at least six of the eight nodes harmonized. The resulting platform, available at https://omicsinharmony.in , supports ontology-aware search, metadata filtering, within- and cross-repository study comparison, and metabolite-level querying, with retrieval backed by machine learning encoders that map study metadata into shared representations of biological and analytical context. HARMONY provides the metabolomics community with a shared, traceable search interface for study discovery and comparison within and across public repositories.
Open AccessOntology-guided harmonization enables unified discovery of public metabolomics studies within and across repositories
Public metabolomics repositories contain thousands of studies, but differences in metadata structure, vocabulary, and repository-specific terms still limit reliable search, comparison, and reuse within and across databases. Here we present HARMONY, an ontology-based framework and web platform that harmonizes study-level metadata and metabolite information across Metabolomics Workbench and MetaboLights studies. HARMONY resolves eight biological and analytical metadata nodes, including species, sample source, disease, analytical technique, separation method, ion polarity, ionization source, and mass analyzer type, while preserving the original deposited terms as evidence. A ninth node, metabolite identity, maps metabolite entities to RefMet across both repositories. HARMONY uses a two-step workflow: Multi-source extraction retrieves records missed by single-field lookups, and ontology mapping then converts repository-specific labels into shared query terms, substantially closing the cross-repository retrieval gap relative to raw matching. Across the full corpus, HARMONY increased cross-repository retrievability from 75.5% to 89.6%, yielding thousands of study-node retrievals and reconnecting studies that raw-text search would have left unreachable within their own repositories. Approximately 91% of Metabolomics Workbench and 85% of MetaboLights studies had at least six of the eight nodes harmonized. The resulting platform, available at https://omicsinharmony.in , supports ontology-aware search, metadata filtering, within- and cross-repository study comparison, and metabolite-level querying, with retrieval backed by machine learning encoders that map study metadata into shared representations of biological and analytical context. HARMONY provides the metabolomics community with a shared, traceable search interface for study discovery and comparison within and across public repositories.
- 3 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 37 (7) , 1536-1549
MetaDilutionR: An R Package for Data-Driven Determination of Optimal Plasma Dilution in Untargeted Metabolomics to Achieve Maximum Metabolite Coverage with ESI Linearity
High-resolution mass spectrometry (HRMS) instruments for untargeted metabolomics typically offer a linear dynamic range spanning approximately 4 orders of magnitude. However, biological samples contain metabolites spanning concentration ranges far exceeding this window, making dilution optimization critical for reliable quantification. Despite its importance, dilution selection in untargeted workflows is rarely standardized and is often determined empirically through manual inspection, leading to operation outside the linear dynamic range, ion suppression, and compromised reproducibility. To address this, we present MetaDilutionR, an open-source R package that standardizes dilution optimization by systematically evaluating electrospray ionization (ESI) linearity using plasma as a model. MetaDilutionR automates dilution assessments, applying user-adjustable slope and R2 thresholds to classify features as linear or nonlinear and executes the complete analysis via a single function call, ensuring algorithmic reproducibility across users and platforms. The package generates comprehensive outputs, including log2-transformed data, a summary of linear features with their optimal dilution ranges, nonlinear features highlighting potential ion suppression or detector saturation, detailed evaluations across dilution scenarios, and visual regression plot reports. Benchmarking against three established metabolomics workflows demonstrated that the R2-slope criterion of MetaDilutionR reduces false-positive linear assignments. Cross-platform applicability of the algorithm on an independent GC-MS data set confirmed consistent classification performance beyond LC-HRMS. By facilitating systematic identification of metabolite-specific optimal dilution conditions, MetaDilutionR enables metabolites to be quantified within their linear dynamic range─a prerequisite for reliable quantification─thereby enhancing reproducibility and consistency of downstream validation, making it readily integrable into existing metabolomics workflows.
- 3 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 37 (7) , 1536-1549
MetaDilutionR: An R Package for Data-Driven Determination of Optimal Plasma Dilution in Untargeted Metabolomics to Achieve Maximum Metabolite Coverage with ESI Linearity
High-resolution mass spectrometry (HRMS) instruments for untargeted metabolomics typically offer a linear dynamic range spanning approximately 4 orders of magnitude. However, biological samples contain metabolites spanning concentration ranges far exceeding this window, making dilution optimization critical for reliable quantification. Despite its importance, dilution selection in untargeted workflows is rarely standardized and is often determined empirically through manual inspection, leading to operation outside the linear dynamic range, ion suppression, and compromised reproducibility. To address this, we present MetaDilutionR, an open-source R package that standardizes dilution optimization by systematically evaluating electrospray ionization (ESI) linearity using plasma as a model. MetaDilutionR automates dilution assessments, applying user-adjustable slope and R2 thresholds to classify features as linear or nonlinear and executes the complete analysis via a single function call, ensuring algorithmic reproducibility across users and platforms. The package generates comprehensive outputs, including log2-transformed data, a summary of linear features with their optimal dilution ranges, nonlinear features highlighting potential ion suppression or detector saturation, detailed evaluations across dilution scenarios, and visual regression plot reports. Benchmarking against three established metabolomics workflows demonstrated that the R2-slope criterion of MetaDilutionR reduces false-positive linear assignments. Cross-platform applicability of the algorithm on an independent GC-MS data set confirmed consistent classification performance beyond LC-HRMS. By facilitating systematic identification of metabolite-specific optimal dilution conditions, MetaDilutionR enables metabolites to be quantified within their linear dynamic range─a prerequisite for reliable quantification─thereby enhancing reproducibility and consistency of downstream validation, making it readily integrable into existing metabolomics workflows.
- Open Access
- 12 May 2026
- Published by American Chemical Society (ACS) in ChemRxiv
MSOne: A deep learning-enabled software suite for end-to-end analysis of high-resolution LC-MS metabolomics data
- 12 May 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessMSOne: A deep learning-enabled software suite for end-to-end analysis of high-resolution LC-MS metabolomics data
- 29 December 2025
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (4) , 899-910
Constraint‐Based Metabolic Modeling of Synechococcus elongatus PCC 11801 and PCC 11802 for Photosynthetic Biomanufacturing
Constraint‐based reconstruction and analysis (COBRA) is a powerful systems biology approach for computational bioengineering. Synechococcus elongatus PCC 11801 and PCC 11802 are fast‐growing, stress‐tolerant cyanobacteria that are promising platforms for photosynthetic biomanufacturing. Here, we present constraint‐based models (CBMs) iLV1052 and iLV1087 of PCC 11801 and PCC 11802, respectively, to facilitate and streamline strain engineering efforts. Following draft reconstruction using a template model, the models underwent extensive manual curation to reduce redundancy, and verification using BiGG, KEGG, and BRENDA databases. We added 281 and 69 new reactions for PCC 11801 and PCC 11802, respectively, associated with stress tolerance, growth stability, antioxidant defense, energy regulation, and sulfur acquisition. The models were refined through iterative debugging and validation using flux balance analysis, flux variability analysis, and single gene/reaction deletion analysis. Gene essentiality predictions gave 69% accuracy for PCC 11801 and 83% for PCC 11802. The flux maps captured key features of cyanobacterial metabolism, including an incomplete TCA cycle. The final PCC 11801 CBM contained 1130 reactions, 1052 genes, and 930 metabolites, while the PCC 11802 CBM included 1199 reactions, 1087 genes, and 951 metabolites. The simulations predicted that succinic acid exhibited the highest theoretical yield among the tested target products in both strains. Using the Optknock framework, phosphoenolpyruvate carboxylase was identified as a metabolic hotspot for future bioengineering efforts aimed at the production of valuable products like ethanol, butanol, and butanediol.
- 29 December 2025
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (4) , 899-910
Constraint‐Based Metabolic Modeling of Synechococcus elongatus PCC 11801 and PCC 11802 for Photosynthetic Biomanufacturing
Constraint‐based reconstruction and analysis (COBRA) is a powerful systems biology approach for computational bioengineering. Synechococcus elongatus PCC 11801 and PCC 11802 are fast‐growing, stress‐tolerant cyanobacteria that are promising platforms for photosynthetic biomanufacturing. Here, we present constraint‐based models (CBMs) iLV1052 and iLV1087 of PCC 11801 and PCC 11802, respectively, to facilitate and streamline strain engineering efforts. Following draft reconstruction using a template model, the models underwent extensive manual curation to reduce redundancy, and verification using BiGG, KEGG, and BRENDA databases. We added 281 and 69 new reactions for PCC 11801 and PCC 11802, respectively, associated with stress tolerance, growth stability, antioxidant defense, energy regulation, and sulfur acquisition. The models were refined through iterative debugging and validation using flux balance analysis, flux variability analysis, and single gene/reaction deletion analysis. Gene essentiality predictions gave 69% accuracy for PCC 11801 and 83% for PCC 11802. The flux maps captured key features of cyanobacterial metabolism, including an incomplete TCA cycle. The final PCC 11801 CBM contained 1130 reactions, 1052 genes, and 930 metabolites, while the PCC 11802 CBM included 1199 reactions, 1087 genes, and 951 metabolites. The simulations predicted that succinic acid exhibited the highest theoretical yield among the tested target products in both strains. Using the Optknock framework, phosphoenolpyruvate carboxylase was identified as a metabolic hotspot for future bioengineering efforts aimed at the production of valuable products like ethanol, butanol, and butanediol.
- Open Access
- 6 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
MSOne: An AI-powered software suite enabling end-to-end analysis of high-resolution LCMS data for metabolomics data mining
Untargeted LC–MS metabolomics generates large, noisy datasets that demand complex, parameter-intensive workflows across multiple software tools. While over 5000 metabolomics datasets are available in public repositories, there are no reports on their re-analysis. Here, we report MSOne (https://msone.claritybiosystems.com), an AI-powered, vendor-agnostic, web-based software suite for end-to-end analysis of raw LC-MS data with minimal parameters. The overall workflow incorporates three modules: MetaExplorer for quality assessment and parameter optimization, MetAnalyzer for AI-assisted preprocessing and annotation, and MetaStat for statistical analysis and visualization. Within MetAnalyzer, mass spectra are first denoised and centroided using a Convolutional Neural Network (CNN) for peak classification and a U-Net-based CNN for peak segmentation. Two other CNNs then repeat this step on chromatographic peaks to minimize the chromatographic noise. RANSAC-guided nonlinear retention-time alignment and graph-based peak grouping ensure robust feature definition, while a rule-driven and peak-to-peak correlation-based tagging classifies isotopes, adducts, and in-source fragments. MS/MS annotation (MSI level 2) applies frequency-based spectral denoising and a composite scoring scheme against public-domain libraries such as MS-DIAL, HMDB, GNPS, and LipidBlast. Benchmarking on public datasets demonstrates superior true-feature recovery, quantitation accuracy, and reproducibility compared to existing tools. A key feature of MSOne is the minimal demand for manual intervention. We have analyzed 80 public domain datasets (and growing) using MSOne, that have been made available in the public domain. Users can explore preprocessed data from MetaMine or submit new data for fresh analysis. MSOne is deployed in Google Cloud, a basic version of which will remain available free of cost to academic users.
- 6 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessMSOne: An AI-powered software suite enabling end-to-end analysis of high-resolution LCMS data for metabolomics data mining
Untargeted LC–MS metabolomics generates large, noisy datasets that demand complex, parameter-intensive workflows across multiple software tools. While over 5000 metabolomics datasets are available in public repositories, there are no reports on their re-analysis. Here, we report MSOne (https://msone.claritybiosystems.com), an AI-powered, vendor-agnostic, web-based software suite for end-to-end analysis of raw LC-MS data with minimal parameters. The overall workflow incorporates three modules: MetaExplorer for quality assessment and parameter optimization, MetAnalyzer for AI-assisted preprocessing and annotation, and MetaStat for statistical analysis and visualization. Within MetAnalyzer, mass spectra are first denoised and centroided using a Convolutional Neural Network (CNN) for peak classification and a U-Net-based CNN for peak segmentation. Two other CNNs then repeat this step on chromatographic peaks to minimize the chromatographic noise. RANSAC-guided nonlinear retention-time alignment and graph-based peak grouping ensure robust feature definition, while a rule-driven and peak-to-peak correlation-based tagging classifies isotopes, adducts, and in-source fragments. MS/MS annotation (MSI level 2) applies frequency-based spectral denoising and a composite scoring scheme against public-domain libraries such as MS-DIAL, HMDB, GNPS, and LipidBlast. Benchmarking on public datasets demonstrates superior true-feature recovery, quantitation accuracy, and reproducibility compared to existing tools. A key feature of MSOne is the minimal demand for manual intervention. We have analyzed 80 public domain datasets (and growing) using MSOne, that have been made available in the public domain. Users can explore preprocessed data from MetaMine or submit new data for fresh analysis. MSOne is deployed in Google Cloud, a basic version of which will remain available free of cost to academic users.
- 6 November 2025
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (1) , 111-128
Effect of Thioredoxin Tag, Oxidizing Environment, and Temperature on the Global Metabolome of E. Coli Strains
Achieving soluble expression of disulfide bond-containing recombinant proteins in Escherichia coli is challenging. While strategies such as low post-induction temperature, fusion tags, and engineered strains have been employed to achieve soluble protein expression, their specific effects on E. coli metabolism and, crucially, how these metabolic shifts relate to the challenge of achieving soluble protein expression remain unclear. Here, we performed untargeted metabolomics to study the key metabolic changes associated with co-expression of fusion tags in E. coli strains at low and high cultivation temperatures. Using a mass spectrometry-based approach, we identified 121 differentially abundant metabolites. The metabolomes of BL21 (DE3) and SHuffle strains exhibited distinct intracellular pools of amino acids and redox regulators. We further studied the expression of platelet-derived growth factor (PDGF) as a model disulfide-rich protein that generally tends to aggregate when expressed in E. coli. A lower induction temperature and the addition of a thioredoxin tag were observed to be crucial for enhancing soluble expression of PDGF in both strains. However, SHuffle showed heightened metabolic stress during PDGF production compared to BL21. Soluble PDGF expression was associated with higher levels of peptides, nucleotides, and glycolysis and TCA cycle intermediates, while PDGF expression as inclusion bodies was associated with higher levels of amino acids, nucleobases, and pentose phosphate pathway intermediates. Our findings highlight the potential of LCMS-based metabolic profiling in understanding the capacities of different host strains for protein processing and guiding metabolic engineering for improved recombinant protein folding and expression in E. coli.
- 6 November 2025
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (1) , 111-128
Effect of Thioredoxin Tag, Oxidizing Environment, and Temperature on the Global Metabolome of E. Coli Strains
Achieving soluble expression of disulfide bond-containing recombinant proteins in Escherichia coli is challenging. While strategies such as low post-induction temperature, fusion tags, and engineered strains have been employed to achieve soluble protein expression, their specific effects on E. coli metabolism and, crucially, how these metabolic shifts relate to the challenge of achieving soluble protein expression remain unclear. Here, we performed untargeted metabolomics to study the key metabolic changes associated with co-expression of fusion tags in E. coli strains at low and high cultivation temperatures. Using a mass spectrometry-based approach, we identified 121 differentially abundant metabolites. The metabolomes of BL21 (DE3) and SHuffle strains exhibited distinct intracellular pools of amino acids and redox regulators. We further studied the expression of platelet-derived growth factor (PDGF) as a model disulfide-rich protein that generally tends to aggregate when expressed in E. coli. A lower induction temperature and the addition of a thioredoxin tag were observed to be crucial for enhancing soluble expression of PDGF in both strains. However, SHuffle showed heightened metabolic stress during PDGF production compared to BL21. Soluble PDGF expression was associated with higher levels of peptides, nucleotides, and glycolysis and TCA cycle intermediates, while PDGF expression as inclusion bodies was associated with higher levels of amino acids, nucleobases, and pentose phosphate pathway intermediates. Our findings highlight the potential of LCMS-based metabolic profiling in understanding the capacities of different host strains for protein processing and guiding metabolic engineering for improved recombinant protein folding and expression in E. coli.
- 17 July 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (8) , 4114-4125
Whole Blood Metabolome Profiling for Stratification of Type 2 Diabetes Patients and Identification of Biomarkers for Diabetic Kidney Disease in Asian Indian Adults
Type 2 diabetes mellitus is a heterogeneous disease with broader metabolic perturbation beyond hyperglycemia, resulting in varied prognoses. Additionally, patients are at risk of complications, such as diabetic kidney disease (DKD), which often remains asymptomatic in early stages. Metabolomics offers a comprehensive assessment of metabolic dysregulation, surpassing conventional biomarkers such as glucose and creatinine. In this case-control study, we used mass spectrometry coupled to liquid (LCMS) and gas chromatography (GCMS) to profile metabolites from the whole blood samples from a cohort of Asian Indians belonging to three groups: nondiabetic, type 2 diabetes, and DKD. We identified 290 metabolites using LCMS and GCMS, of which 26 and 20 metabolites were significantly associated with type 2 diabetes and DKD, respectively, after false discovery rate correction. Clustering analyses revealed two distinct subgroups within the type 2 diabetes group, with nine metabolites linked to the disease severity. Additionally, seven metabolites exhibited progressive changes from nondiabetic to type 2 diabetes to DKD, suggesting potential prognostic markers for DKD. Our study highlights the role of metabolome profiling for patient stratification and early diagnosis of DKD in Indian patients with type 2 diabetes.
- 17 July 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (8) , 4114-4125
Whole Blood Metabolome Profiling for Stratification of Type 2 Diabetes Patients and Identification of Biomarkers for Diabetic Kidney Disease in Asian Indian Adults
Type 2 diabetes mellitus is a heterogeneous disease with broader metabolic perturbation beyond hyperglycemia, resulting in varied prognoses. Additionally, patients are at risk of complications, such as diabetic kidney disease (DKD), which often remains asymptomatic in early stages. Metabolomics offers a comprehensive assessment of metabolic dysregulation, surpassing conventional biomarkers such as glucose and creatinine. In this case-control study, we used mass spectrometry coupled to liquid (LCMS) and gas chromatography (GCMS) to profile metabolites from the whole blood samples from a cohort of Asian Indians belonging to three groups: nondiabetic, type 2 diabetes, and DKD. We identified 290 metabolites using LCMS and GCMS, of which 26 and 20 metabolites were significantly associated with type 2 diabetes and DKD, respectively, after false discovery rate correction. Clustering analyses revealed two distinct subgroups within the type 2 diabetes group, with nine metabolites linked to the disease severity. Additionally, seven metabolites exhibited progressive changes from nondiabetic to type 2 diabetes to DKD, suggesting potential prognostic markers for DKD. Our study highlights the role of metabolome profiling for patient stratification and early diagnosis of DKD in Indian patients with type 2 diabetes.